Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients

Oncology Letters

Volumn 7, Issue 6, 2014, Pages 1944-1950

  Antunes Jr , Armando ^a   Vassallo, José ^a   Pinheiro, Anderson ^a   Leão, Rogério ^a   Pinto Neto, Aarão Mendes ^a   Costa Paiva, Lucia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Endometrial polyp; Estrogen receptor; Postmenopausal; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AUTOREGULATION; ENDOMETRIUM POLYP; FEMALE; HISTOLOGY; HUMAN; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; POSTMENOPAUSE; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY;

EID: 84898886582     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2004     Document Type: Article

References (25)

1. Kurman RL: Blaustein's Pathology of the Female Genital Tract. 5th edition. Springer, New York, pp448-450, 2002.
2. Haimov-Kochman R, Deri-Hasid R, Hamani Y and Voss E: The natural course of endometrial polyps: Could they vanish when left untreated? Fert Steril 92: 828, 2009.
3. Dreisler E, Stampe SS, Ibsen PH and Lose G: Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 33: 102-108, 2009.
4. Lee SC, Kaunitz AM, Ramos LS and Rhatigan RM: The oncogenic potential of endometrial polyps. A Systematic Review and Meta-Analysis. Obstet Gynecol 116: 1197-1205, 2010.
5. Antunes A Jr, Costa-Paiva L, Arthuso M, Costa JV and Pinto-Neto AM: Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy. Maturitas 57: 415-421, 2007.
6. Oguz S, Sargin A, KeleKei S, Aytan H, Tapisiz OL and Mollamahmutoglu L: The role of hormone replacement therapy in endometrial polyp formation. Maturitas 50: 231-236, 2005.
7. Lopes RG, Baracat EC, de Albuquerque Neto LC, et al: Analysis of estrogen-and progesterone-receptor expression in endometrial polyps. J Minim Invasive Gynecol 14: 300-303, 2007.
8. Almeida ECS, Nogueira AA, Reis FJC, Ramalho LNZ and Zucoloto S: Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 49: 229-233, 2004.
9. Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, et al: Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 61: 24-28, 2006.
10. Gul A, Ugur M, Iskender C, Zulfikaroglu E and Ozaksit G: Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters. Arch Gynecol Obstet 281: 479-483, 2010.
11. Fons G, Hasibuan SM, van der Velden J and ten Kate FJ: Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol 60: 500-503, 2007.
12. Harvey JM, Clark GM, Osbome CK and Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481, 1999.
13. Costa-Paiva L, Godoy Jr CE, Antunes Jr A, Caseiro JD, Arthuso M and Pinto-Neto AM: Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause 18: 1-5, 2011.
14. Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN and Liberis VA: Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 21: 180-183, 2000.
15. Martinez MA, Jou P, Nonell R, Cardona M, Alonso I and Vanrell JA: Endometrial polyps: risk of malignancy and clinical-anatomical correlation. Prog Obstet Ginecol 47: 506-510, 2004.
16. Speroff L: The estrogen receptor: changing concepts. Clinical lessons from molecular biology. In: Reproductive Medicine - A Millennium Review. Coutinho EM and Spinola P (eds). Parthenon Publishing Group, New York, pp155-161, 1999.
17. Yen SSC: Human menstrual cycle. In: Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. Yen SSC, Jaffe RB and Barbieri RL (eds). Saunders, Philadelphia, pp193-227, 1999.
18. Longcope C and Baker S: Androgen and estrogen dynamics: relationships with age, weight and menopausal status. J Clin Endocrinol Metabol 76: 601-604, 1993.
19. McGurgan P, Taylor LJ, Duffy SR and O'Donovan PJ: Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre-and post-menopausal women. Maturitas 54: 277-284, 2006.
20. Pickartz H, Beckmann R, Fleige B, Due W, Gerdes J and Stein H: Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria. Virchows Arch A: Pathol Anat Histopathol 417: 163-171, 1990.
21. Giuffre G, Arena F, Scarfi R, Simone A, Todaro P and Tuccari G: Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Oncol Rep 16: 257-263, 2006.
22. Moshin SK, Weiss H, Havighurst T, Clark GM, Beraldo M, Roanhle D, et al: Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 17: 1545-1554, 2004.
23. Ito K, Utsunomiya H, Yaegashi N and Sasano H: Biological roles of estrogen and progesterone in human endometrial carcinoma-new developments in potential endocrine therapy for endometrial cancer. Endocr J 54: 667-679, 2007.
24. Iversen OE, Utaaker E and Skaarland E: DNA ploidy steroid receptors as predictors of disease course in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 67: 531-537, 1988.
25. Sivridis E, Giatromanolaki A, Koukourakis M and Anastasiadis P: Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch 438: 470-477, 2001.